Nihon Kohden (OTCMKTS:NHNKY) Posts Earnings Results, Beats Expectations By $0.28 EPS

Nihon Kohden (OTCMKTS:NHNKY) posted its quarterly earnings data on Thursday. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.28, Zacks reports. The firm had revenue of $453.10 million during the quarter, compared to analysts’ expectations of $414.40 million. Nihon Kohden had a return on equity of 7.25% and a net margin of 5.32%.

Nihon Kohden Price Performance

NHNKY traded up $0.58 on Friday, reaching $9.29. 8,936 shares of the stock were exchanged, compared to its average volume of 29,792. The company’s 50-day moving average price is $9.46 and its 200 day moving average price is $10.51. Nihon Kohden has a fifty-two week low of $8.71 and a fifty-two week high of $14.21. The firm has a market capitalization of $1.59 billion, a PE ratio of 18.22 and a beta of 0.41.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the company. UBS Group raised Nihon Kohden from a “hold” rating to a “strong-buy” rating in a research report on Monday, January 19th. Zacks Research raised Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy”.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.